KYTX(KYTX)
KYTX
ANALYST COVERAGE4 analysts
BUY
▲ +274.9%upside to target
L $25.00
Med $32.50consensus
H $33.00Key MetricsTTM
Market Cap$379.67M
Revenue TTM—
Net Income TTM—
Free Cash Flow—
Gross Margin—
Operating Margin—
Net Margin—
Return on Equity-81.9%
Return on Assets—
Debt / Equity0.05
Current Ratio8.15
EPS TTM$-2.59
PRICE
Prev Close
8.90
Open
8.90
Day Range8.56 – 9.07
8.56
9.07
52W Range2.43 – 13.67
2.43
13.67
56% of range
VOLUME & SIZE
Avg Volume
907.3K
FUNDAMENTALS
P/E Ratio
-2.6x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
42
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 24
DEx-Dividend
In 90 days
Aug 21
PDividend Pay
In 128 days
Sep 28
KYTX News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Tom Van BlarcomSenior Vice President & Head of Research
Dan MaziaszChief Business Officer
Christi L. ShawExecutive Chairperson
Naji GehchanChief Medical & Development Officer
Jessica SerraHead of Investor Relations
Mayo PujolsChief Technology Officer
Warner BiddleChief Executive Officer & Director
Cara BauerChief Human Resources Officer
Marc GrassoChief Financial Officer
Tracy RossinSenior Vice President of Corporate Affairs & Communications and Investor Relations